Legal Opinion
In Re Immune Response Securities Litigation
District Court, S.D. California
Decided June 7, 2005No. 01CV1237JWMCPublishedCited by 43 opinions
1Opinion of the Court
ORDER: (1) DENYING DEFENDANTS’ MOTIONS TO DISMISS THE COMPLAINT; AND (2) DENYING DEFENDANTS’ REQUESTS FOR JUDICIAL NOTICE
JONES, District Judge.
This is a class action 1 on behalf of all persons (“Plaintiffs”) who bought shares of Immune Response Corporation (“IRC”) between May 17, 1999 and July 6, 2001 (the “Class Period”). (Comply 1.) Plaintiffs allege IRC and its representatives made false and misleading statements about the efficacy of REMUNE — a drug IRC developed for the treatment of human immunodeficiency virus (“HIV”). Specifically, Plaintiffs allege securities fraud under the 1933…
2Cases cited91 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Neitzke v. WilliamsSupreme Court of the United States · 1989
- Ernst & Ernst v. HochfelderSupreme Court of the United States · 1976
- Associated General Contractors of California, Inc. v. California State Council of CarpentersSupreme Court of the United States · 1983
- Basic Inc. v. LevinsonSupreme Court of the United States · 1988
86 more not listed; retrieve them via the Exa API.
3Cited by43 opinions
- Karim Khoja v. Orexigen Therapeutics, Inc.Court of Appeals for the Ninth Circuit · 2018
- In re Facebook, Inc., IPO Securities & Derivative LitigationDistrict Court, S.D. New York · 2014
- In Re Bear Stearns Companies, Inc. Securities, Derivative, & Erisa LitigationDistrict Court, S.D. New York · 2011
- Betz v. Trainer Wortham & Co., Inc.Court of Appeals for the Ninth Circuit · 2007
- In re Facebook, Inc., IPO Securities & Derivative LitigationDistrict Court, S.D. New York · 2013
38 more not listed; retrieve them via the Exa API.